Perioperative medicine & outcomes

Efficacy and safety of perioperative esketamine in improving postoperative sleep disturbances: A systematic review and meta-analysis

J Clin AnesthPublished Systematic review and meta-analysis of randomised trials

Authors' conclusion

Perioperative esketamine effectively reduces the incidence of early postoperative sleep disturbances and improves subjective sleep quality in adult surgical patients, with the timing of administration being the primary source of heterogeneity.

Study context

Population
Adult surgical patients
Participants
1,956 patients · 14 randomized controlled trials (RCTs)
Comparison
Perioperative IV esketamine vs control
Outcome
Postoperative sleep disturbance scale score and incidence of postoperative sleep disturbances (PSD%)
Follow-up
First postoperative night
Methodological detailssubgroup analysis
  • Subgroup analysis

Pooled result

As reported in the abstract

POD1
Esketamine vs ControlOdds ratio (95% CI)P value
PSD%
0.38(0.29–0.50)
P < 0.00001
Esketamine vs ControlSMD (95% CI)P value
Subjective sleep quality; I2 = 88%
−0.63(−1.09 to −0.16)
P = 0.009

Further pooled results

Postoperative sleep quality by administration mode (subgroup)

Both single-dose and continuous intraoperative esketamine consistently improved postoperative sleep quality

Postoperative pain scores

No statistically significant difference between esketamine and control

Postoperative rescue analgesia

Significantly lower incidence in the esketamine group

Safety

Adverse events

Only drowsiness markedly increased with esketamine; no significant differences for other adverse reactions

Original publication

Efficacy and safety of perioperative esketamine in improving postoperative sleep disturbances: A systematic review and meta-analysis. J Clin Anesth. Published 8 June 2026. doi:10.1016/j.jclinane.2026.112246

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.